DMEPOS Accreditation Bodies Compared: ACHC, CHAP, Joint Commission, and NCOAM

For DMEPOS suppliers, accreditation is not optional: Medicare requires it for billing, and many commercial payers follow suit. But the choice of accrediting organization is less straightforward. Suppliers considering ACHC, CHAP, the Joint Commission, or NCOAM face differences in survey philosophy, cost structure, specialty focus, and payer recognition. This analysis looks at recent trends, what separates the four, and what suppliers should weigh before committing to a multi-year accreditation cycle.

Recent Trends in DMEPOS Accreditation

Accreditation requirements have grown more demanding in recent years as CMS has tightened supplier standards around documentation, beneficiary protections, and quality improvement. Surveyors now devote more attention to compliance history, complaint logs, and evidence of ongoing oversight.

• Remote and hybrid surveys have become routine, reducing on-site travel but creating new challenges around documentation readiness.
• New DMEPOS benefit categories, including advanced prosthetics and glucose monitoring technologies, have pushed accreditors to develop product-specific survey tools.
• Suppliers are comparing accreditors more deliberately as commercial insurers apply standards beyond Medicare’s baseline.

Background: How the Accreditors Differ

Each of the four organizations holds CMS deeming authority, meaning it can certify that a supplier meets Medicare’s DMEPOS quality and safety standards. The practical differences lie in market focus, survey approach, and reputational footprint.

• ACHC — A broad-scope accreditor with a large DMEPOS supplier base. Its surveys are often described as consultative, with an emphasis on education and continuous readiness.
• CHAP — Rooted in community health and home care, CHAP applies a person-centered lens to DMEPOS standards. It tends to appeal to suppliers already aligned with home health and hospice settings.
• The Joint Commission — Best known for hospital and ambulatory care accreditation. Its DMEPOS program leverages a legacy of patient-safety standards, which can carry weight with health systems and referral partners.
• NCOAM — A specialized accreditor focused on orthotic and prosthetic suppliers. It is a relevant option for businesses that want surveyors with deep experience in the O&P field rather than general DMEPOS categories.

When choosing, suppliers typically compare the following:

• Scope of accreditation: general DMEPOS versus O&P specialization
• Survey style: consultative versus compliance-centered
• Recognized status with Medicare and private payers
• Fee structure: application, annual, and re-survey costs
• Scheduling availability and geographic coverage

User Concerns: Choosing an Accreditor

Suppliers report a common set of concerns when evaluating accreditors. The most immediate is ensuring the chosen organization is accepted by both Medicare and the commercial plans the supplier bills. A secondary concern is survey readiness: many suppliers underestimate the documentation burden and face corrective action plans after their initial survey.

• Commercial payer recognition can differ by region and contract; suppliers should verify acceptance before making a switch.
• Survey cycles typically run three years, but re-survey preparation should start early, especially if the supplier expects changes in product lines or ownership.
• Switching accreditors mid-cycle can create gaps in accreditation status, which may interrupt Medicare billing — a major disincentive to change without careful timing.
• Cost visibility is a recurring concern, as application fees, annual fees, and travel-related surveyor expenses can add up for small suppliers.

Likely Impact

The accreditor choice can shape a supplier’s operational focus well beyond the survey itself. A supplier that serves mostly O&P patients may find NCOAM’s specialized standards more relevant, while a supplier selling across multiple DMEPOS categories may prefer ACHC or CHAP’s broader framework. The Joint Commission’s name recognition may support relationships with hospital-based referral sources.

• Medicare billing continuity depends on maintaining accreditation without lapses; the cost of switching must be weighed against any perceived benefit.
• Commercial payer contracts increasingly ask about accreditation status, and in some cases, payers stipulate a specific accreditor.
• Suppliers planning to expand into new product lines should confirm that their accreditor’s standards cover those categories adequately.
• Staff training and quality programs are often built around the accreditor’s manual, so the chosen framework affects everyday operations.

What to Watch Next

Accreditation policy remains fluid. CMS periodically reviews accrediting organizations and can add or withdraw deeming authority, and commercial payers are updating supplier requirements in response to value-based purchasing trends.

• Watch for CMS rulemaking on supplier standards, including any changes to the accreditation requirement itself.
• Monitor whether the four accreditors expand or narrow their DMEPOS program scopes, especially as new device categories emerge.
• Track consolidation in the accreditation market; a merger or exit could affect suppliers currently accredited by one of these bodies.
• Expect continued growth in remote and hybrid survey methods, potentially lowering costs but raising expectations for digital documentation and audit trails.